$DYAI Dyadic to Present at ZAPI Stakeholders Virtu
Post# of 42658
JUPITER, FL / ACCESSWIRE / February 3, 2021 / Dyadic International, Inc. ("Dyadic" (NASDAQ YAI), a global biotechnology company focused on further improving and applying its proprietary C1 gene expression platform to accelerate development, lower production costs, and improve the performance of vaccines, drugs and other biological products at flexible commercial scales, today announced that Ronen Tchelet, PhD, Dyadic's Chief Scientific Officer, will make a presentation during the European Union Innovative Medicines Initiative (IMI) Zoonotic Anticipation Preparedness Initiative - ZAPI Stakeholders Virtual Web Meeting to be held on February 4th and 5th, 2021.
https://finance.yahoo.com/news/dyadic-present...00732.html